Company Filing History:
2 out of 265 
2 out of 3 
1 out of 1 Years Active: 1997
Title: **Andreas Immelmann: Innovator in Viral Disease Therapeutics**
Introduction
Andreas Immelmann is a notable inventor based in Düsseldorf, Germany. With a total of three patents to his name, he has made significant contributions to the field of viral disease diagnostics and therapeutics.
Latest Patents
Immelmann's latest patents address critical aspects of viral health. His work on HIV-2 virus variants has led to the identification of two specific variants, HIV D194 and HIV D205. These variants can be cloned from the corresponding virus isolates, as well as from the infected cell line HUT 194, enabling advancements in diagnostic and therapeutic strategies. Additionally, he has developed novel compounds such as γ-pyrones, γ-pyridones, and γ-thiopyrones. These compounds are designed to be used as medicaments targeting viral diseases, particularly retroviral infections, emphasizing their potential in clinical applications.
Career Highlights
Throughout his career, Andreas Immelmann has contributed to significant projects while collaborating with notable companies in the pharmaceutical and research sectors. He has been associated with Qiagen GmbH, which is known for its genetic testing and diagnostic solutions, and Chemotherapeutisches Forschunginstitut Georg-Speyer-Haus, where he advanced research focused on therapeutic innovations.
Collaborations
Immelmann has worked alongside esteemed colleagues, including Karsten Henco and Hagen von Briesen. Their collaborative efforts have contributed to the progression of research in viral therapeutics, enhancing the potential for effective treatments and diagnostics in the field.
Conclusion
Andreas Immelmann's innovative spirit and dedication to combating viral diseases through his patents provide valuable insights into future therapeutic avenues. His work is vital in the ongoing fight against viral infections, and his inventions stand to make a significant impact in the medical community.